TGF-β attenuates the cytotoxic function of NK cells and CTLs and leads the conversion of NK cells into type 1 innate lymphoid cells in the TME, which fail to suppress tumor growth and metastasis [29, 30]. The gene discussed is TGFB1; the disease is neoplasm.